DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kineret (Anakinra) - Current Clinical Trials


Kineret Related Clinical Trials

A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis [Terminated]

Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease [Recruiting]

Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria [Completed]

Anakinra (Kineret«) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) [Completed]

Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients [Recruiting]

Anakinra to Prevent Adverse Post-infarction Remodeling (2) [Completed]

Anakinra as a Treatment for Hydradenitis Suppurativa [Completed]

Kineret CAPS Post Authorisation Study [Recruiting]

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma [Not yet recruiting]

Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis [Recruiting]

A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease [Completed]

Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss [Enrolling by invitation]

Anakinra and Kawasaki Disease [Not yet recruiting]

Anakinra to Prevent Post-infarction Remodeling [Completed]

Anakinra in Hidradenitis Suppurativa [Completed]

Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes [Completed]

Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3) [Recruiting]

AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIR TRIP) [Recruiting]

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma [Completed]

Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction [Completed]

Evaluating Kineret´┐Ż (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire [Completed]

Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes [Recruiting]

A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy [Active, not recruiting]

Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis [Recruiting]

Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection [Not yet recruiting]

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study [Recruiting]

Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus [Recruiting]

Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study [Active, not recruiting]

Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer [Recruiting]

Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease [Completed]

REKinDLE: Registry With Enbrel« or Kineret« in a Database Using Longitudinal Evaluations [Completed]

Anakinra for Behcet s Disease [Completed]

Interleukin-1 Receptor Antagonist and Insulin Sensitivity [Active, not recruiting]

Anakinra for Inflammatory Pustular Skin Diseases [Recruiting]

Cytokine Inhibition in Chronic Fatigue Syndrome Patients [Recruiting]

Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) [Completed]

Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study [Completed]

Treatment for Patients With Osteoarthritis (OA) of the Knee [Completed]

Interleukin-1 Blockade in Recently Decompensated Heart Failure [Recruiting]

Ineterleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF) [Recruiting]

Anti-Interleukin-1 in Diabetes Action [Completed]

Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain [Recruiting]

Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure [Completed]

Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sj├Şgrens Syndrome [Completed]

Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension [Terminated]

Juvenile Rheumatoid Arthritis [Completed]

Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy [Active, not recruiting]

Cyanobacteria Allergy in Lake Kineret [Not yet recruiting]

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study [Recruiting]

Anakinra in Myositis [Completed]


Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene [Completed]

Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis [Active, not recruiting]

The SPECTRA Study [Terminated]

Interleukin-1 Blockade in HF With Preserved EF [Recruiting]

Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients [Completed]

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease [Terminated]

IL-1RA, Acute Exercise, and Beta-cell Function [Recruiting]

Study to Prevent Cartilage Damage Following Acute Knee Injury. [Completed]

Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers [Completed]

Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis [Completed]

Anti-IL-1 Treatment in Children DKA at Diagnosis of Type 1 Diabetes [Recruiting]

Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2 [Recruiting]

Topical IL-1-Ra for Treatment of Posterior Blepharitis [Completed]

Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA) [Active, not recruiting]

Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation [Completed]

Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus [Recruiting]

Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors [Recruiting]

Treatment for Patients With Osteoarthritis (OA) [Completed]

Rilonacept (Arcalyst ´┐Ż) in the Treatment of Subacromial Bursitis [Completed]

Ilaris (Canakinumab) in the Schnitzler Syndrome [Completed]

Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy [Recruiting]

Tocilizumab for Relapsing Polychondritis [Withdrawn]

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease [Terminated]

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017